Demonstrates improved yield of chiral alcohols in engineered carbonyl reductases, highlighting biocatalysis advancements.
Carbonyl reductases (CRs) are a class of oxidoreductases that convert carbonyl groups into hydroxyl groups. The application of CRs in the refined chemical industry is hindered by an unclear catalytic mechanism and low catalytic activity. In this study, CpCR from Candida parapsilosis ATCC 7330 was engineered via error-prone PCR and semirational design. The T171F mutant exhibited 2-fold enhanced catalytic efficiency toward PAAH, with an extended t 1/2 by 7.0 h and elevated T 50 by 1 °C. Consequently, 2-phenethyl alcohol (2-PE) production achieved a yield of 91.31%, representing a 2.36-fold improvement over wtCpCR. Simultaneously, the P284D/P285W variant displayed 6.2-fold higher k cat / K m toward CPMK and increased T 50 by 2 °C. ( S )-(4-Chlorophenyl)(pyridin-2-yl)methanol (CPMA) synthesis using P284D/P285W reached 42.71% yield, which is 9.23-fold greater than that of wtCpCR. Molecular dynamics simulations provided mechanistic insights into enhanced catalytic efficiency. This study establishes rational strategies for CR evolution and advances the green biosynthesis of high-value chiral alcohols.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: